Your browser doesn't support javascript.
loading
Diagnostic accuracy of 68 Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of 68 Ga-PSMA PET to mpMRI.
Scheltema, Matthijs J; Chang, John I; Stricker, Phillip D; van Leeuwen, Pim J; Nguyen, Quoc A; Ho, Bao; Delprado, Warick; Lee, Jonathan; Thompson, James E; Cusick, Thomas; Spriensma, Alette S; Siriwardana, Amila R; Yuen, Carlo; Kooner, Raji; Hruby, George; O'Neill, Gordon; Emmett, Louise.
  • Scheltema MJ; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
  • Chang JI; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
  • Stricker PD; Amsterdam UMC, Department of Urology, Amsterdam, The Netherlands.
  • van Leeuwen PJ; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
  • Nguyen QA; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
  • Ho B; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
  • Delprado W; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
  • Lee J; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
  • Thompson JE; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
  • Cusick T; Antoni van Leeuwenhoek Nederlands Kanker Instituut, Amsterdam, The Netherlands.
  • Spriensma AS; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
  • Siriwardana AR; St Vincent's Hospital Nuclear Medicine and PET Department, Darlinghurst, NSW, Australia.
  • Yuen C; Douglass Hanly Moir Pathology, Macquarie Park, NSW, Australia.
  • Kooner R; St Vincent's Hospital Nuclear Medicine and PET Department, Darlinghurst, NSW, Australia.
  • Hruby G; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
  • O'Neill G; St Vincent's Prostate Cancer Centre, Darlinghurst, NSW, Australia.
  • Emmett L; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
BJU Int ; 124 Suppl 1: 42-49, 2019 11.
Article en En | MEDLINE | ID: mdl-31287613
ABSTRACT

OBJECTIVE:

To evaluate the ability of prostate-specific membrane antigen (PSMA)-positron-emission tomography (PET)/computed tomography (CT) to detect intermediate-grade intra-prostatic prostate cancer (PCa), and to determine if PSMA-PET improves the diagnostic accuracy of multiparametric magnetic resonance imaging (mpMRI). PATIENTS AND

METHODS:

A total of 56 consecutive patients with International Society of Urological Pathology (ISUP) grade 2-3 PCa after radical prostatectomy, who underwent both mpMRI and PSMA-PET CT (hereafter PSMA-PET) preoperatively, were enrolled in this study. The accuracy of PSMA-PET, mpMRI alone, and the two procedures in combination was analysed for identifying ISUP grades 1-3 within a 12-segment model. The accuracy of a combined predictive model (PSMA-PET and mpMRI) was determined. Receiver-operating characteristic curve analysis to determine the optimal standardized uptake value (SUVmax ) for PSMA-PET in discriminating between ISUP grades 1 and ≥2 was performed.

RESULTS:

On a per-patient basis, the sensitivities for PSMA-PET and mpMRI in identifying ISUP grades 2-3 PCa were 100% and 97%, respectively. Assessing ISUP grade ≥2 PCa using a 12-segment analysis, PSMA-PET demonstrated greater diagnostic accuracy (area under the curve), sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV), with values of 0.91, 88%, 93%, 95% and 85%, respectively, than did mpMRI (Prostate Imaging Reporting and Data System [PI-RADS] 3-5), at 0.79, 68%, 91%, 87%, and 75%, respectively. When used in combination (PSMA-PET and mpMRI PIRADS 4-5), sensitivity, specificity, NPV and PPV were 92%, 90%, 96% and 81%, respectively. The sensitivity for both techniques reduced markedly when assessing ISUP grade 1 PCa (18% for PSMA-PET, 10% for mpMRI). An SUVmax value of 3.95 resulted in 94% sensitivity and 100% specificity.

CONCLUSION:

PSMA-PET is accurate in detecting segments containing intermediate-grade intra-prostatic PCa (ISUP grade ≥ 2), compared with and complementary to mpMRI. By contrast the detection rate for ISUP grade 1 disease for both PSMA-PET and mpMRI was low.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Próstata / Prostatectomía / Neoplasias de la Próstata / Radiofármacos / Tomografía Computarizada por Tomografía de Emisión de Positrones / Radioisótopos de Galio / Imágenes de Resonancia Magnética Multiparamétrica Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Próstata / Prostatectomía / Neoplasias de la Próstata / Radiofármacos / Tomografía Computarizada por Tomografía de Emisión de Positrones / Radioisótopos de Galio / Imágenes de Resonancia Magnética Multiparamétrica Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article